Dostarlimab in the treatment of recurrent or primary advanced endometrial cancer

Future Oncology, Ahead of Print.

Source: Future Oncology - November 30, 2020 Category: Cancer & Oncology Authors: Lawrence Kasherman Soha Ahrari Stephanie Lheureux Source Type: research